I can't help but think this is some major repositioning in the biotech indexes, like what happened when DNDN hit. VRTX tanking, IDIX ready to cross the gap, some biotechs way down, some way up. Not that GTCB's news is as big as the DNDN effect...just that overall, the biotech index isn't going down for long and different players will hold it up and raise it higher.